British Standards
The requirements for blood bags are defined in British
Standard BS 2463-"Transfusion equipment for medical use", Part 1:
Specifications for collapsible containers for blood and blood components.
British Standard BS 5736 "Evaluation of medical devices
to biological hazards" Parts 1 to 6 describes tests to be done to assess a
device as being free from biological hazard.
| Table-3
: Biological Tests for various Categories of
Medical Devices BS 5736 Part-1 1989 |
Tests
|
Device Category |
| A1 |
A2 |
A3 |
B |
C1 |
C2 |
C3 |
Cell Culture
Irritation
Tissue Implantation
Intracutaneous
reactivity
Systemic toxicity
Haemolysis
Sensitisation
|
-
+
-
-
-
-
+ |
+
+
-
+
+
+
+ |
+
+
-
-
-
-
+ |
+
-
-
+
+
+
+ |
+
-
+/-
+
-
-
+ |
+
-
-
-
+
+
+ |
+
-
+
+
+
-
+ |
Part 1 : Guide for the selection of biological methods of
test, clearly defines medical devices into three distinct categories depending
on their mode of application and also specifies the biological tests necessary
for their evaluation (Table-3).
Categories of Medical Devices
BS 5736 Part-1
Category-A : External Contact
Those devices coming into contact either directly or
indirectly :
-
A1 With intact skin. (Eg. Electrodes and external
prostheses)
-
A2 With breached or otherwise damaged skin. (Eg. Wounded
dressings)
-
A3 With eyes. (Eg. Contact lenses and eye drop containers)
Category-B : Indirect Internal Contact
Those devices used to contain or administer substances
including blood, which are introduced parenterally into the body.
Eg. Intravenoiss administration sets, Hypodermic syringes,
Blood bags.
Category-C : Direct Internal Contact
-
C1 With intact natural channels. (Eg. Urinary catheters,
Intra uterine devices, Stomach tubes, Tracheal tube)
-
C2 With circulating blood. (Eg. Haemodialysis equipment,
Intra vascular catheters)
-
C3 With other body tissues and fluids. (Eg. Hip
prostheses, Breast implants, Ligation clips)
German Standard – DIN 58361
"Transfusion, infusion, transfusion containers and
accessories, empty bags of plastics, safety requirements, testing supervision
and labeling".
This standard specifies the physical, chemical and biological
requirements for blood bags, the materials used in their manufacture and tests
to be done.
The biological tests specified are systemic injection test on
mice-using normal saline and vegetable oils as extracting medium and haemolysis.
Tests to be done on Blood based on the Specifications of various Standards
The International Standards ISO 3826 meets the requirements
of all other standards. However, certain additional tests described in other
standards are also included in the list below.
1.0 General
Transparent, flexible, non-pyrogenic and non-toxic.
2.0 Design Requirements
3.0 Physical Requirements
-
Manufactured under GMP requirements
-
Sterilised by autoclaving
-
Transparency
-
Colouration
-
Vapour transmission
-
Resistance to distortion
-
Resistance to leakage
-
Thermal stability
-
Performance of marking and labeling
-
Legibility of printed matter on labels
-
Resistance to dropping *
-
Impermeability to micro-organisms *
Tubing – additional tests
[Note: * German Pharmacopoeia. # DHSS specifications]
4.0 Chemical Requirements
1. On water extract
-
Oxidisable matter (0.5N Thiosulphate ml) < 2
-
Ammonia (mg/l) < 2
-
Chloride (mg/l) < 4
-
Acidity / Alkalinity
0.01 Mol / L NaoH < 0.4
0.01 Mol / L Hcl < 0.8
-
Residue on evaporation
(mg/100 ml) 3.0
-
Opalescence (Reference suspension 2) 3.0
-
Colouration Nil
-
UV Absorption (range
230-360 mm) < 0.2
-
Extractable (di 2 ethyl hexyl phthalate) (mg/100 ml) 10.00
2. On plastics
Heavy metals (mg/kg.)
5.0 Recommended Biological Tests
Type and Lot Tests
It is utmost importance that the formulation of the PVC
compound and the method of manufacture and processing should not be varied once
a compound has been developed and validated. It is even desirable to procure raw
materials and additives form a single supplier of proven consistency and
reliability.
Type Tests
Type tests should be established on the basis of :
-
Compatibility of the material of the plastic container
with the anticoagulant/and/or preservative solution blood and blood
components.
-
Compatibility of the plastic container with the process
of manufacture and sterilisation.
-
General biological safety of plastics container
-
Biological safety of plastics containers with cellular
elements of blood and blood components.
The plastic containers should not release any substances
which may adversely affect the therapeutic effectivensss of blood and blood
components including substances which may exhibit toxic, cytotoxic,
bacteriostatic, bactericidal, pyrogenic or haemolytic reactions.
Type tests are to be done on the following:
-
New plastic formulations i.e. when different plastics
are introduced.
-
On already agreed formulations in which any change has
been made i.e. when for example a pthalate is substituted by another type of
plasticizer or when a stabiliser is replaced by another of different
composition.
-
On change of anticoagulant and/or preservative
solutions.
The type tests to be done as per ISO 3826 are :
Lot Tests
These are tests that should be done on each manufacturing
"lot". ISO 3826 define "lot" as follows:
For plastics containers containing anticoagulant and/or
preservative solution, "lot" is that quantity of plastics containers
prepared, filled from a single batch of anticoagulant solution and sterilised
within a continuous working period.
For plastics containers not containing an anticoagulant
and/or preservative solution, the term "lot" means that quantity of
plastics containers prepared within one working day and sterilised in one cycle.
However, a manufacturer may apply a different definition of
the terms "lot" for his proprietary manufacturing process without
sacrificing quality assurance (GMP) in any way.
GMP and Quality Assurance
In the above discussion, GMP and Quality Assurance have not
been discussed in detail. It goes without saying that GMP and Quality Assurance
procedures are strictly followed right from the selection of raw materials,
their processing, preparation of anticoagulants, sterilisation, post
sterilisation processing, packaging, labeling, cartoning and despatch. Most
vital requirements are validation of every operation and equipment used,
adequate documentation and traceability.
Conclusions
The use of PVC for critical medical products involves utmost
care and dedication at every step. Testing, quality assurance and validation
requires that quite a number of physical, chemical and biological tests have to
be done on a regular basis to ensure that the products manufactured consistently
conform to the high standards required for life saving devices.
|